RxNorm Concept ID 1100075

abiraterone acetate 250 MG Oral Tablet

Semantic Concepts

RxNorm semantic concepts for the RxCUI 1100075 unique identifier include: abiraterone acetate 250 MG Oral Tablet (6369209), abiraterone acetate 250 MG Oral Tablet (3638822), Abiraterone acetate 250 mg oral tablet (9248312) and Product containing precisely abiraterone acetate 250 milligram/1 each conventional release oral tablet (clinical drug) (10308781).

RxNorm Atom ID: 6369209 - Prescribable Name

abiraterone acetate 250 MG Oral Tablet

Field NameField ValueField Description
RXCUI1100075RxNorm Unique Identifier for a concept (Concept ID)
LATENGLanguage of the Term
RXAUI6369209Unique identifier for the atom (RxNorm Atom ID)
Concept Descriptionabiraterone acetate 250 MG Oral TabletDescription of concept identifier
Term Type (TTY)PSNTerm type in source with name and description
Term Type NamePrescribable NameName of term type in source
Term Type DescriptionSynonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.Description of term type in source
CODE1100075"Most useful" source asserted identifier. If the source vocabulary has more than one identifier, or a RxNorm-generated source entry identifier. (if the source vocabulary has none.)
Is Prescribable?YESThis drug is part of the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States. The Current Prescribable subset also includes over-the-counter drugs.
Suppress FlagNSuppressible flag. Values = N, O, Y, or E. N - not suppressible. O - Specific individual names (atoms) set as Obsolete because the name is no longer provided by the original source. Y - Suppressed by RxNorm editor. E - unquantified, non-prescribable drug with related quantified, prescribable drugs. NLM strongly recommends that users not alter editor-assigned suppressibility.
CVF4096Content view flag. RxNorm includes one value, '4096', to denote inclusion in the Current Prescribable Content subset. All rows with CVF='4096' can be found in the subset.
SourceRXNORMConcept source abbreviation
Source NameRxNorm VocabularyThe official name for a source
Source Version20AA_230103FThe source version
Source DateJanuary 03, 2023RxNorm data last updated
Source License ContactRxNorm Customer Service

U.S. National Library of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
(888) FIND-NLM

[email protected]
https://www.nlm.nih.gov/research/umls/rxnorm/
The source license contact information
Source Content ContactRxNorm Customer Service

U.S. National Library of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
(888) FIND-NLM

[email protected]
https://www.nlm.nih.gov/research/umls/rxnorm/
The source content contact information
Source Short NameRxNorm work done by the National Library of MedicineThe short name of a source as used by the NLM Knowledge Source Server

RxNorm Atom ID: 3638822 - Semantic Clinical Drug

abiraterone acetate 250 MG Oral Tablet

Field NameField ValueField Description
RXCUI1100075RxNorm Unique Identifier for a concept (Concept ID)
LATENGLanguage of the Term
RXAUI3638822Unique identifier for the atom (RxNorm Atom ID)
Concept Descriptionabiraterone acetate 250 MG Oral TabletDescription of concept identifier
Term Type (TTY)SCDTerm type in source with name and description
Term Type NameSemantic Clinical DrugName of term type in source
Term Type DescriptionIngredient + Strength + Dose FormDescription of term type in source
CODE1100075"Most useful" source asserted identifier. If the source vocabulary has more than one identifier, or a RxNorm-generated source entry identifier. (if the source vocabulary has none.)
Is Prescribable?YESThis drug is part of the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States. The Current Prescribable subset also includes over-the-counter drugs.
Suppress FlagNSuppressible flag. Values = N, O, Y, or E. N - not suppressible. O - Specific individual names (atoms) set as Obsolete because the name is no longer provided by the original source. Y - Suppressed by RxNorm editor. E - unquantified, non-prescribable drug with related quantified, prescribable drugs. NLM strongly recommends that users not alter editor-assigned suppressibility.
CVF4096Content view flag. RxNorm includes one value, '4096', to denote inclusion in the Current Prescribable Content subset. All rows with CVF='4096' can be found in the subset.
SourceRXNORMConcept source abbreviation
Source NameRxNorm VocabularyThe official name for a source
Source Version20AA_230103FThe source version
Source DateJanuary 03, 2023RxNorm data last updated
Source License ContactRxNorm Customer Service

U.S. National Library of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
(888) FIND-NLM

[email protected]
https://www.nlm.nih.gov/research/umls/rxnorm/
The source license contact information
Source Content ContactRxNorm Customer Service

U.S. National Library of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
(888) FIND-NLM

[email protected]
https://www.nlm.nih.gov/research/umls/rxnorm/
The source content contact information
Source Short NameRxNorm work done by the National Library of MedicineThe short name of a source as used by the NLM Knowledge Source Server

RxNorm Atom 3638822 Attributes

PropertyValueExplanation
RXN AI{1100073} 1100071RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AM{1100073} 1100072RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AVAILABLE STRENGTH250 MG (expressed as abiraterone acetate)Available drug strengths listed in the order of ingredients from the drug
RXN BOSS FROM{1100073} AISource of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN HUMAN DRUGUSDrug available for use in Humans
RXTERM FORMTabThe RxTerm dose form name for this drug

RxNorm Atom ID: 9248312 - Designated preferred name

Abiraterone acetate 250 mg oral tablet

Field NameField ValueField Description
RXCUI1100075RxNorm Unique Identifier for a concept (Concept ID)
LATENGLanguage of the Term
RXAUI9248312Unique identifier for the atom (RxNorm Atom ID)
Concept DescriptionAbiraterone acetate 250 mg oral tabletDescription of concept identifier
Term Type (TTY)PTTerm type in source with name and description
Term Type NameDesignated preferred nameName of term type in source
Term Type DescriptionDescription of term type in source
CODE703904004"Most useful" source asserted identifier. If the source vocabulary has more than one identifier, or a RxNorm-generated source entry identifier. (if the source vocabulary has none.)
Is Prescribable?YESThis drug is part of the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States. The Current Prescribable subset also includes over-the-counter drugs.
Suppress FlagNSuppressible flag. Values = N, O, Y, or E. N - not suppressible. O - Specific individual names (atoms) set as Obsolete because the name is no longer provided by the original source. Y - Suppressed by RxNorm editor. E - unquantified, non-prescribable drug with related quantified, prescribable drugs. NLM strongly recommends that users not alter editor-assigned suppressibility.
CVFContent view flag. RxNorm includes one value, '4096', to denote inclusion in the Current Prescribable Content subset. All rows with CVF='4096' can be found in the subset.
SourceSNOMEDCT_USConcept source abbreviation
Source NameUS Edition of SNOMED CTThe official name for a source
Source Version2022_07_31The source version
Source DateJanuary 03, 2023RxNorm data last updated
Source License ContactNational Library Of Medicine
NLM is a Charter Member of SNOMED International on behalf of the U.S.
National Library of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
1-888-FIND-NLM (1-888-346-3656)

https://support.nlm.nih.gov/support/create-case/
The source license contact information
Source Content ContactNational Library Of Medicine
NLM is a Charter Member of SNOMED International on behalf of the U.S.
National Library Of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
1-888-FIND-NLM (1-888-346-3656)

https://support.nlm.nih.gov/support/create-case/
The source content contact information
Source Short NameUS Edition of SNOMED CTThe short name of a source as used by the NLM Knowledge Source Server

RxNorm Atom ID: 10308781 - Full form of descriptor

Product containing precisely abiraterone acetate 250 milligram/1 each conventional release oral tablet (clinical drug)

Field NameField ValueField Description
RXCUI1100075RxNorm Unique Identifier for a concept (Concept ID)
LATENGLanguage of the Term
RXAUI10308781Unique identifier for the atom (RxNorm Atom ID)
Concept DescriptionProduct containing precisely abiraterone acetate 250 milligram/1 each conventional release oral tablet (clinical drug)Description of concept identifier
Term Type (TTY)FNTerm type in source with name and description
Term Type NameFull form of descriptorName of term type in source
Term Type DescriptionDescription of term type in source
CODE703904004"Most useful" source asserted identifier. If the source vocabulary has more than one identifier, or a RxNorm-generated source entry identifier. (if the source vocabulary has none.)
Is Prescribable?YESThis drug is part of the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States. The Current Prescribable subset also includes over-the-counter drugs.
Suppress FlagNSuppressible flag. Values = N, O, Y, or E. N - not suppressible. O - Specific individual names (atoms) set as Obsolete because the name is no longer provided by the original source. Y - Suppressed by RxNorm editor. E - unquantified, non-prescribable drug with related quantified, prescribable drugs. NLM strongly recommends that users not alter editor-assigned suppressibility.
CVFContent view flag. RxNorm includes one value, '4096', to denote inclusion in the Current Prescribable Content subset. All rows with CVF='4096' can be found in the subset.
SourceSNOMEDCT_USConcept source abbreviation
Source NameUS Edition of SNOMED CTThe official name for a source
Source Version2022_07_31The source version
Source DateJanuary 03, 2023RxNorm data last updated
Source License ContactNational Library Of Medicine
NLM is a Charter Member of SNOMED International on behalf of the U.S.
National Library of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
1-888-FIND-NLM (1-888-346-3656)

https://support.nlm.nih.gov/support/create-case/
The source license contact information
Source Content ContactNational Library Of Medicine
NLM is a Charter Member of SNOMED International on behalf of the U.S.
National Library Of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
1-888-FIND-NLM (1-888-346-3656)

https://support.nlm.nih.gov/support/create-case/
The source content contact information
Source Short NameUS Edition of SNOMED CTThe short name of a source as used by the NLM Knowledge Source Server

* This product uses publicly available data courtesy of the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Information for Patients

Abiraterone

Abiraterone is used in combination with prednisone to treat a certain type of prostate cancer that has spread to other parts of the body. Abiraterone is in a class of medications called androgen biosynthesis inhibitors. It works by decreasing the amount of certain hormones in the body.
[Read More]
Cancer Chemotherapy

Normally, your cells grow and die in a controlled way. Cancer cells keep growing without control. Chemotherapy is drug therapy for cancer. It works by killing the cancer cells, stopping them from spreading, or slowing their growth. However, it can also harm healthy cells, which causes side effects.

You may have a lot of side effects, some, or none at all. It depends on the type and amount of chemotherapy you get and how your body reacts. Some common side effects are fatigue, nausea, vomiting, pain, and hair loss. There are ways to prevent or control some side effects. Talk with your health care provider about how to manage them. Healthy cells usually recover after chemotherapy is over, so most side effects gradually go away.

Your treatment plan will depend on the cancer type, the chemotherapy drugs used, the treatment goal, and how your body responds. Chemotherapy may be given alone or with other treatments. You may get treatment every day, every week, or every month. You may have breaks between treatments so that your body has a chance to build new healthy cells. You might take the drugs by mouth, in a shot, as a cream, or intravenously (by IV).

NIH: National Cancer Institute


[Read More]

* Please review the disclaimer below.